Clinical Trials Insight: 700037565

Trial Profile

Clinical Trials Insight: 700037565

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2013

At a glance

  • Drugs Glatiramer acetate (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Teva Pharmaceutical Industries
  • Most Recent Events

    • 26 Feb 2010 15-year results were published in Multiple Sclerosis, according to a Teva Pharmaceuticals media release.
    • 12 Sep 2009 Interim results preseneted at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
    • 11 Sep 2009 Teva Pharmaceuticals report that results will be presented at ECTRIMS 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top